The Role of Tofacitinib in the Management of Alopecia .
作者信息
Hernandez-Montoya Carlos, Ruiz-Villaverde Ricardo
机构信息
Department of Dermatology, Hospital de Poniente, El Ejido, Spain.
Department of Dermatology, Hospital Universitario San Cecilio, Granada, Spain.
出版信息
Sultan Qaboos Univ Med J. 2019 Feb;19(1):e77-e78. doi: 10.18295/squmj.2019.19.01.015. Epub 2019 May 30.
Abstract
摘要
相似文献
1
The Role of Tofacitinib in the Management of Alopecia .托法替布在斑秃治疗中的作用
Sultan Qaboos Univ Med J. 2019 Feb;19(1):e77-e78. doi: 10.18295/squmj.2019.19.01.015. Epub 2019 May 30.
2
Comparison of the Treatment Outcome of Oral Tofacitinib with Other Conventional Therapies in Refractory Alopecia Totalis and Universalis: A Retrospective Study.口服托法替尼与其他常规疗法治疗难治性全秃和普秃的疗效比较：一项回顾性研究。
Acta Derm Venereol. 2019 Jan 1;99(1):41-46. doi: 10.2340/00015555-3057.
3
Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients.托法替尼治疗严重斑秃及其变异型：90 例患者研究。
J Am Acad Dermatol. 2017 Jan;76(1):22-28. doi: 10.1016/j.jaad.2016.09.007. Epub 2016 Nov 2.
4
Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis.外用2%托法替布治疗斑秃、全秃和普秃儿童。
J Am Acad Dermatol. 2018 Jun;78(6):1207-1209.e1. doi: 10.1016/j.jaad.2018.02.031.
5
Efficacy of tofacitinib in treatment of alopecia universalis in two patients.托法替布治疗两名泛发性斑秃患者的疗效。
J Eur Acad Dermatol Venereol. 2016 Aug;30(8):1373-8. doi: 10.1111/jdv.13598. Epub 2016 Jun 15.
6
Tofacitinib for the treatment of alopecia areata and variants in adolescents.托法替尼治疗青少年斑秃及变异型。
J Am Acad Dermatol. 2017 Jan;76(1):29-32. doi: 10.1016/j.jaad.2016.09.006. Epub 2016 Nov 2.
7
Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction.局部托法替尼促进非瘢痕性脱发毛发生长的疗效：通过诱导 VEGF 的可能机制。
Arch Dermatol Res. 2017 Nov;309(9):729-738. doi: 10.1007/s00403-017-1777-5. Epub 2017 Sep 7.
8
An Excellent Response to Tofacitinib in a Pediatric Alopecia Patient: A Case Report and Review.托法替布对一名儿童脱发患者的显著疗效：病例报告及文献复习
J Drugs Dermatol. 2018 Aug 1;17(8):914-917.
9
Antibodies against hair follicles are associated with alopecia totalis in autoimmune polyendocrine syndrome type I.抗毛囊抗体与自身免疫性多内分泌腺综合征I型中的全秃相关。
J Invest Dermatol. 1999 Dec;113(6):1054-8. doi: 10.1046/j.1523-1747.1999.00778.x.
10
引用本文的文献
1
Efficacy of Oral Tofacitinib in Alopecia Areata, Alopecia Totalis, and Alopecia Universalis.口服托法替布治疗斑秃、全秃和普秃的疗效。
Cureus. 2025 Apr 18;17(4):e82536. doi: 10.7759/cureus.82536. eCollection 2025 Apr.
2
Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety.托法替布和巴瑞替尼在希腊斑秃患者中的真实世界用药经验：一项聚焦安全性的回顾性分析
Dermatol Pract Concept. 2024 Apr 1;14(2):e2024073. doi: 10.5826/dpc.1402a73.
3
Granzyme B Inhibition by Tofacitinib Blocks the Pathology Induced by CD8 T Cells in Cutaneous Leishmaniasis.托法替尼抑制颗粒酶 B 阻断 CD8 T 细胞诱导的皮肤利什曼病病理。
J Invest Dermatol. 2021 Mar;141(3):575-585. doi: 10.1016/j.jid.2020.07.011. Epub 2020 Jul 30.
本文引用的文献
1
Tofacitinib for the treatment of alopecia areata in preadolescent children.托法替布用于治疗青春期前儿童斑秃。
J Am Acad Dermatol. 2019 Feb;80(2):568-570. doi: 10.1016/j.jaad.2018.08.041. Epub 2018 Sep 6.
2
Emerging drugs for alopecia areata: JAK inhibitors.斑秃的新兴药物：JAK 抑制剂。
Expert Opin Emerg Drugs. 2018 Mar;23(1):77-81. doi: 10.1080/14728214.2018.1444750. Epub 2018 Feb 26.
3
Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology.托法替布，一种口服的 Janus 激酶抑制剂：皮肤病学中的应用前景
Curr Med Chem. 2017 May 31;24(11):1158-1167. doi: 10.2174/1874467210666170113104503.
Zotero 插件